Centene Corporation key statistics and ratios
In fiscal 2025, Centene Corporation had return on equity of -28.8%, an operating margin of -3.9%, debt equal to 87.7% of equity and a current ratio of 1.10. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 95.4% | 96.2% | 96.0% | 96.7% | 97.0% | 11.5% | 11.7% | 11.5% | 10.5% | 7.3% | 7.9% |
| Operating margin | 3.4% | 3.5% | 3.9% | 1.3% | 2.5% | 2.8% | 3.1% | 3.1% | 2.5% | 2.4% | 2.4% | 2.8% | 1.4% | 0.9% | 1.9% | 1.9% | −3.9% | 0.5% |
| Net margin | 2.0% | 2.1% | 2.1% | 0.0% | 1.5% | 1.6% | 1.6% | 1.4% | 1.7% | 1.5% | 1.8% | 1.6% | 1.1% | 0.8% | 1.8% | 2.0% | −3.4% | 0.7% |
| Free-cash-flow margin | 5.5% | 1.1% | 3.6% | 2.4% | 2.9% | 6.8% | 2.2% | 3.8% | 2.2% | 0.9% | 1.0% | 4.2% | 2.6% | 3.6% | 4.7% | −0.3% | 2.2% | 1.9% |
| Return on equity | 13.9% | 13.6% | 12.9% | 0.2% | 15.1% | 18.2% | 18.2% | 14.0% | 13.0% | 10.1% | 11.3% | 9.4% | 5.1% | 4.7% | 10.8% | 12.7% | −28.8% | 6.9% |
| Return on assets | 4.9% | 5.2% | 5.4% | 0.1% | 5.2% | 5.8% | 5.4% | 4.1% | 3.9% | 3.4% | 3.7% | 3.3% | 1.8% | 1.5% | 3.3% | 4.0% | −8.4% | 1.9% |
| Asset turnover | 2.41 | 2.44 | 2.52 | 3.27 | 3.45 | 3.54 | 3.46 | 2.95 | 2.30 | 2.28 | 2.08 | 2.03 | 1.71 | 1.86 | 1.91 | 1.95 | 2.45 | 2.61 |
| Current ratio | 0.86 | 0.86 | 1.12 | 1.14 | 1.15 | 1.02 | 0.99 | 0.97 | 0.93 | 1.00 | 1.57 | 1.08 | 1.11 | 1.06 | 1.11 | 1.11 | 1.10 | 1.16 |
| Debt to equity | 51.2% | 41.6% | 37.6% | 56.5% | 54.2% | 50.4% | 56.7% | 81.1% | 70.5% | 62.8% | 110.4% | 65.5% | 71.0% | 75.6% | 69.5% | 70.6% | 87.7% | 70.0% |
| Interest cover (operating income ÷ interest) | 8.5x | 8.7x | 10.0x | 5.4x | 10.3x | 13.3x | 16.4x | 5.8x | 4.7x | 4.3x | 4.3x | 4.2x | 2.7x | 2.0x | 4.0x | 4.5x | n/m | 1.6x |
| Effective tax rate | 35.5% | 38.8% | 37.5% | 38.2% | 39.8% | 42.9% | 48.6% | 51.6% | 28.7% | 34.6% | 26.5% | 35.3% | 26.3% | 38.7% | 25.0% | 22.6% | — | 23.9% |
| SG&A as % of revenue | — | — | — | — | — | 7.8% | 7.9% | 9.0% | 9.2% | 10.1% | 8.8% | 8.4% | 7.6% | 8.0% | 8.2% | 7.6% | 6.6% | 6.4% |
| Capital spending as % of revenue | 0.6% | 2.7% | 1.4% | 1.0% | 0.6% | 0.6% | 0.7% | 0.8% | 0.9% | 1.1% | 1.0% | 0.8% | 0.7% | 0.7% | 0.5% | 0.4% | 0.4% | 0.4% |
| Free cash flow ÷ net income | 268.3% | 53.1% | 169.0% | >999% | 190.3% | 413.3% | 143.1% | 274.9% | 128.9% | 62.1% | 57.0% | 256.3% | 244.6% | 437.4% | 268.5% | −14.8% | — | 270.1% |
| Dividends and buybacks ÷ free cash flow | 2.8% | 6.4% | 4.2% | 6.6% | 6.1% | 2.6% | 10.4% | 4.1% | 6.1% | 12.7% | 10.0% | 13.5% | 9.0% | 58.9% | 22.5% | — | 11.0% | 1.5% |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 9.3% | 11.3% | 6.2% | 6.7% | 5.1% | 11.3% | 8.6% | 6.5% |
| Operating margin | 0.4% | 3.3% | −0.9% | −14.0% | −3.5% | 3.7% | 2.2% | −0.6% |
| Net margin | 0.7% | 2.8% | −0.5% | −13.3% | −2.2% | 3.1% | 2.0% | −0.1% |
| Free-cash-flow margin | −1.8% | 2.9% | 3.2% | 2.3% | 0.5% | 8.3% | 6.4% | −7.6% |
| Current ratio | 1.11 | 1.11 | 1.10 | 1.08 | 1.10 | 1.12 | 1.15 | 1.16 |
| Debt to equity | 70.2% | 65.6% | 64.1% | 83.9% | 87.2% | 76.4% | 71.4% | 70.0% |
| SG&A as % of revenue | 7.9% | 7.2% | 6.2% | 6.3% | 6.8% | 6.8% | 5.8% | 6.4% |
Financial health
- Short-term assets cover short-term liabilities $45.5bn of assets due within a year against $39.1bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $45.5bn short-term assets against $17.9bn of longer-dated liabilities.
- More cash than debt $20.7bn of cash against $15.5bn of debt.
- Debt below 40% of shareholders' equity Debt is 70% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 69% to 70% over five years.
- A year's operating cash flow covers at least 20% of debt $4.7bn of operating cash flow against $15.5bn of debt.
- Operating profit covers interest at least five times over Operating income of $1.0bn against $634m of interest.
Moat
Weak moat
How hard Centene's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 2 / 20
Net income has been a median 2.9% of total assets over 10 years.
- Durability 0 / 20
Operating margin has been a median 1.8%; its worst year was -3.1%.
- Cash conversion 11 / 20
Free cash flow was positive in 10 of 10 years, at a median 2.5% of revenue.
- Discipline 20 / 20
The diluted share count fell 15.9% over five years; stock-based pay has been a median 0.2% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (41 before it).
Compare with peers
- Elevance Health statistics
- Humana statistics
- UnitedHealth Group statistics
- Molina Healthcare, Inc. statistics
- Oscar Health, Inc. statistics
Head to head: CNC vs ELVCNC vs HUMCNC vs UNH
More: Managed Health Care stocks compared, Health Care sector, rankings of US companies